• Biotin (Vitamin B7) for Motor Protein Assays

  2026-08-14

  Biotin (Vitamin B7) enables controlled avidin–streptavidin capture, blocking, and detection workflows for reconstituted motor-protein experiments. This guide connects A8010’s practical solution chemistry with the BicD–MAP7–kinesin findings, while clarifying when free biotin is appropriate and when an activated biotinylation reagent is required.

• DAPI Nuclear Stain Solution Protocol

  2026-08-14

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a pre-diluted fluorescent DNA binding dye for nuclear visualization and endpoint cell viability assessment. It is best suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, not primary live-cell imaging.

• Cholesterol Hinders Lipid Nanoparticle Trafficking

  2026-08-13

  This study introduces a sensitive imaging platform to track nucleic acid-containing lipid nanoparticles through endocytotic and endolysosomal compartments. Its central finding is that increasing cholesterol can promote aggregation of LNP-containing early endosomes near the cell periphery, hindering trafficking toward compartments associated with cargo release.

• Aurora A, SAM Metabolism, and Trained Immunity

  2026-08-13

  Li et al. identify Aurora kinase A as a metabolic and epigenetic regulator of β-glucan-trained immunity, linking kinase activity to the mTOR–FOXO3–GNMT axis and endogenous S-adenosylmethionine availability. The study provides a mechanistic framework for interpreting how Aurora A inhibition can alter inflammatory chromatin states and immune-mediated tumor responses.

• (+)-Bicuculline: Protocol and QC Guide

  2026-08-12

  (+)-Bicuculline (SKU N1592) provides a controlled pharmacological perturbation of GABAA-mediated inhibition for neuroscience research workflows, including synaptic signaling and selected memory-model studies. It is a research-use compound only and should not be used for diagnostic, clinical, or therapeutic applications.

• Vitamin C (CAS 50-81-7): Assay Reliability

  2026-08-12

  This scenario-based guide explains how Vitamin C (CAS 50-81-7), SKU B2064, can support more interpretable cell viability, proliferation, senescence, and cytotoxicity experiments. It combines product specifications with peer-reviewed evidence and practical controls for dosing, preparation, and data interpretation.

• Perphenazine: From D2 Signaling to Host Defense

  2026-08-11

  Perphenazine is a dopamine D2 receptor antagonist with a distinctive research profile spanning receptor pharmacology, mitochondrial injury, opioid tolerance suppression, and macrophage defense. This article presents an evidence-based framework for separating target engagement from cell stress and host-directed antibacterial activity.

• DPPH: From Radical Signal to Study Decisions

  2026-08-11

  DPPH and 2,2-Diphenyl-1-Picrylhydrazyl Radical chemistry provide a rapid foundation for in vitro antioxidant screening. This guide explains how to interpret DPPH results alongside orthogonal assays, analytical profiling, and natural-product decision workflows.

• Cholesterol Hinders LNP Intracellular Trafficking

  2026-08-10

  The 2025 International Journal of Pharmaceutics study introduced a sensitive imaging platform to follow nucleic acid-loaded lipid nanoparticles through intracellular compartments. Its results indicate that increasing cholesterol can promote aggregation of LNP-containing early endosomes, restrict endolysosomal progression, and reduce access to compartments associated with cargo release.

• Breast Cancer Dependence on MCL-1: Study Insights

  2026-08-09

  This 2021 study shows that established breast tumours depend on MCL-1 primarily because of its canonical anti-apoptotic activity, rather than an exclusively non-apoptotic function. Genetic deletion and pharmacological inhibition both required BAX/BAK to suppress tumour growth, linking MCL-1 targeting directly to mitochondrial apoptosis and offering a framework for interpreting MCL-1 inhibitor studies.

• Aprotinin at the Translational Frontier

  2026-08-08

  A mechanistic and strategic guide to Aprotinin, or bovine pancreatic trypsin inhibitor, connecting fibrinolysis inhibition, cardiovascular surgery blood management, inflammation, and red blood cell membrane biomechanics.

• Cell Cycle Assay Kit: Workflow & Troubleshooting

  2026-08-07

  Turn DNA-content histograms into actionable evidence of cell-cycle arrest, proliferation changes, and apoptosis. This workflow shows how the Cell Cycle Assay Kit (K2263) can strengthen oncology experiments, including studies of GANT61-treated ALK-positive anaplastic large cell lymphoma.

• Sodium Nitroprusside: Applied Workflows in Vascular Hyperten

  2026-08-07

  Sodium Nitroprusside empowers researchers to dissect sex-specific vascular responses and optimize hypertension models via precise nitric oxide donation. This article delivers step-by-step protocols, advanced assay design, and troubleshooting strategies informed by landmark studies. Discover how APExBIO’s reagent unlocks nuanced control in vascular smooth muscle and platelet function research.

• SLC2A5-Driven Fructose Metabolism in Primary CNS Lymphoma

  2026-08-06

  This study uses single-cell multi-omics to reveal how SLC2A5-mediated fructose metabolism becomes a metabolic vulnerability in primary CNS lymphoma (PCNSL) under hypoxic, glucose-deprived conditions. The findings highlight therapeutic opportunities targeting fructose uptake in both tumor cells and supportive macrophages, with implications for future metabolic intervention strategies.

• MK-571 (L-660,711): Applied Workflows in Inflammation Resear

  2026-08-06

  MK-571 (L-660,711) stands out as both a precise leukotriene D4 receptor antagonist and a robust tool for dissecting multidrug resistance in immune assays. Recent mechanistic studies open new avenues for optimizing immune cell protection protocols and deepening our understanding of inflammation and chemotherapy cross-talk.

11850 records 1/790 page Next 12345 下5页 Last page